Fredrik Schjesvold is the head of the Oslo Myeloma Center in Oslo, Norway. He is head of the Norwegian Myeloma Association, president-elect of the Nordic Myeloma Study Group, and a member of the European Myeloma Network board. He has been a national investigator on 36 clinical trials in multiple myeloma and principal investigator for four academic trials. He is a coauthor of ESMO and IMWG guidelines and lead author of the Norwegian myeloma guidelines. He is a peer reviewer of several international journals and coeditor of the journal Hemato. He is an international expert on myeloma and has given talks in Europe, North America, and Asia.